04/02/2026
RiboCeineβ’ is an advanced form of D-ribose and L-cysteine designed to deliver Cysteine more effectively into cells, where it can support the bodyβs production of Glutathione.
Scientific research, including work by Dr Jeanette C Roberts and colleagues, has shown that in liver cells, this Cysteine delivery system raises intracellular Glutathione much more effectively than traditional NAC (N-acetylcysteine).
In a controlled liver cell model, RiboCeineβ’ boosted Glutathione levels in hepatocytes by up to 300 % compared with NAC under similar conditions and significantly exceeded by 800 % the impact of direct oral Glutathione. These findings highlight RiboCeineβ’βs unique mechanism in supporting endogenous Glutathione synthesis, providing a stronger foundation for cellular antioxidant defence and liver cell function.
NAC reliably delivers the building blocks the body needs to support Glutathione synthesis increase by 276 %, while standard oral Glutathione is largely broken down in the digestive tract before it reaches cells. This makes NAC a more effective oral approach for increasing the bodyβs own Glutathione production than taking Glutathione directly.